Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage |
Project Objective![]() |
Details |
---|---|---|---|---|---|---|
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Personalized cell therapy | BrainStorm |
![]() |
Clinical Trial, Phase 3 | |
Liver Disease | iPS Cell | Diagnostic Test | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Development Candidate, Proof of Concept | |
Cartilage defect | Adult Stem Cell | Biologic | The Stone Research Foundation for Sports Medicine and Arthritis |
![]() |
Development Candidate, Proof of Concept | |
Brain Cancer, Neurological Disorders |
Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Cartilage defect, Osteoarthritis |
Embryonic Stem Cell | Therapeutic Approach | Scripps Health |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Vaccine | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Spinal Cord Injury | Embryonic Stem Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Research Insights | |
Anemia |
Adult Stem Cell, iPS Cell |
Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Dementia | iPS Cell | Donor cell therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | iPS Cell | Biologic | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Heart failure | iPS Cell | Exosomes based therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Liver Disease | iPS Cell | Gene-modified, donor cell therapy | CHLA |
![]() |
Development Candidate, Proof of Concept | |
Muscle Injury | Adult Stem Cell | Personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | Sanford-Burnham |
![]() |
Development Candidate, Proof of Concept | |
Angelman Syndrome, Autism |
iPS Cell | Gene Therapy, cell free | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Skeletal/Smooth Muscle disorders |
Embryonic Stem Cell, iPS Cell |
Exosomes based therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Salk |
![]() |
Development Candidate, Proof of Concept | |
Traumatic Brain Injury | Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept, Research Insights | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Breast Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Cytonus Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Heart Disease | iPS Cell | Model system development | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Heart failure | Adult Stem Cell | Nucleic acid based therapy | Cedars-Sinai |
![]() |
Development Candidate, Proof of Concept | |
Other | Adult Stem Cell | Protein/peptide therapy | Intact Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders | iPS Cell | Gene Therapy, cell free | Navega Therapeutics |
![]() |
Development Candidate, Proof of Concept | |
Spinal Cord Injury | iPS Cell | Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Multiple Myeloma | Somatic Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Multiple Sclerosis | Adult Stem Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Lundquist Institute |
![]() |
Development Candidate, Proof of Concept | |
Kidney Disease | Somatic Cell | Gene Therapy, cell free | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Inflammatory bowel disease | Adult Stem Cell | Donor cell therapy | Vitabolus, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Heart Disease | iPS Cell | Donor cell therapy | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
iPS Cell | Gene-modified, personalized cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Traumatic Brain Injury | iPS Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Research Insights | |
COVID-19 | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Pancreatic Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Huntington's Disease | iPS Cell | Gene Therapy, cell free | UCSD |
![]() |
Development Candidate, Proof of Concept | |
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND |